AGQ Labs
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
AGQ Labs - overview
Established
1993
Location
Seville, -, Spain
Primary Industry
Chemicals
About
Based in Sevilla, Spain, and founded in 1993 by Estanislao Martínez and Coral Zamora, AGQ Technological Corporate SL doing business AGQ Labs specializes in analytical and consulting services. In October 2025, Fremman Capital has acquired a 35% stake in AGQ Labs from Portobello Capital. AGQ Labs specializes in analytical solutions and consulting services aimed at enhancing sustainability, efficiency, and productivity across various sectors. The company offers a comprehensive suite of services that includes environmental analysis, laboratory testing, and quality control, particularly within the pharmaceutical and agricultural industries.
Their core offerings address challenges faced by clients, ensuring compliance with international standards, improving product quality, and optimizing resource management. AGQ Labs serves a diverse client base that includes governmental agencies, multinational corporations, and small to medium-sized enterprises across multiple geographic markets, including Europe, Africa, and Latin America, focusing on food safety, water management, energy, and life sciences.
Current Investors
Portobello Capital
Primary Industry
Chemicals
Sub Industries
Consulting Services, Engineering, Diagnostic, Medical & Imaging Laboratories, Agricultural Chemicals
Website
www.agq.com.es
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
AGQ Labs - timeline of key events
AGQ Labs - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 8,904,020.5 | 9,154,304 | 10,713,676.6 | 10,594,548.6 | 11,850,552.1 | 10,496,513.4 | 9,580,728.4 | - | - | - |
| % Revenue Growth (YoY) | - | 2.8% | 17.0% | (1.1%) | 11.9% | (11.4%) | (8.7%) | - | - | - |
| EBITDA (USD) | 2,091,661.6 | 2,096,323.2 | 2,991,260.5 | 2,128,948.7 | 2,204,976.1 | 2,419,380.1 | 938,709 | - | - | - |
| Operating Income (USD) | 896,354 | 986,691.1 | 1,900,274.5 | 1,229,870.7 | 1,357,225.1 | 1,578,277.1 | 188,558 | - | - | - |
| Operating Margin | 10.1% | 10.8% | 17.7% | 11.6% | 11.5% | 15.0% | 2.0% | - | - | - |
| % EBITDA Margin | 23.5% | 22.9% | 27.9% | 20.1% | 18.6% | 23.0% | 9.8% | - | - | - |
| NET Income (USD) | 692,809.3 | 811,174.9 | 1,736,782.8 | 1,165,823.6 | 1,430,585.8 | 1,526,216.1 | 126,089.1 | - | - | - |
| % Net Margin | 7.8% | 8.9% | 16.2% | 11.0% | 12.1% | 14.5% | 1.3% | - | - | - |
AGQ Labs - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | AGQ Labs | - | ||||||||
| Add-on | Completed | Microbiología y Calidad Industrial MCI S.A. | - | ||||||||
| Add-on | Completed | Netpharmalab Consulting Services S.L. | - | ||||||||
| Buyout | Completed | AGQ Labs | - |
Displaying 1 - 4 of 4
AGQ Labs - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.